Pharmacovigilance market update
A European perspective 2016
With more stringent government drug safety regulations, rising rates of adverse drug reactions and the increasing cost of new drug development, pharmacovigilance faces many challenges and much change. But what are the opportunities for professionals and organisations alike?
In our latest spotlight on pharmacovigilance we examine:
- The growing regulatory challenge
- The dynamic market
- Buoyant demand
- Future opportunities